Oral anticoagulation with apixaban after TAVR not superior to the standard of care: Study Medical Dialogues Editorial Team25 May 2022 2:30 AM GMTFrance: In a new study conducted by Jean-Philippe Collet and the team, it was shown that Apixaban was not superior to the standard of care after...
Rate of structural valve deterioration lower with TAVR than with SAVR Dr. Kamal Kant Kohli9 April 2022 3:45 AM GMTPatients who received a transcatheter supra-annular self-expanding heart valve had significantly less structural deterioration in the valve after five...
TAVR safe and efficient procedure for same day discharge Dr. Nandita Mohan29 March 2022 11:45 AM GMTThe covid-19 pandemic has taken lives uncountably and making patients critical. There has been huge scarcity for hospitalization and availability of...
Cerebral Protection System reduces rates of CV events and mortality after TAVR MD Bureau21 March 2022 3:30 AM GMTAlmost 4% of individuals over 70 and more than 9% over 80 years of age suffer from severe aortic stenosis (AS). Transcatheter aortic valve replacement...
Fewer Than Half patients with Severe Aortic Stenosis Get New Valves MD Bureau12 March 2022 4:30 AM GMTTreatment of severe aortic stenosis (AS) with surgical or transcatheter aortic valve replacement (AVR) reduces mortality and rehospitalization,...
Use of cusp-overlapping projection in TAVR reduces rate of permanent pacemaker implantation: JACC Medha Baranwal9 March 2022 3:30 AM GMTSpain: A novel cusp-overlapping projection (COP) technique was shown to significantly reduce the rate of permanent pacemaker implantation (PPMI) in...
Infective endocarditis caused by S. aureus after TAVR tied to high in-hospital and late mortality: Study Medha Baranwal14 Feb 2022 3:30 AM GMTCanada: A recent study in the Canadian Journal of Cardiology showed that Staphylococcus aureus (SA) infective endocarditis (IE) represents 25% of IE...
Mortality, stroke rates similar at 5-years with TAVR versus SAVI: SURTAVI trial Medha Baranwal5 Jan 2022 4:30 AM GMTDelhi: Patients at intermediate surgical risk who underwent transcatheter aortic valve replacement (TAVR) versus surgery had similar rates of...
Experts Suggest Long Term Monitoring After TAVI To Address Delayed Conduction Problem MD Bureau24 Dec 2021 3:30 AM GMTTranscatheter aortic valve replacement (TAVR) has revolutionized the management of aortic stenosis worldwide. Recently, concerns have been raised...
Edoxaban noninferior to vitamin K antagonists for atrial fibrillation after successful TAVR: ENVISAGE-TAVI AF trial Medha Baranwal27 Nov 2021 3:30 AM GMTDelhi: Findings from the ENVISAGE-TAVI AF trial showed edoxaban to be noninferior to vitamin K antagonists in patients with mainly prevalent atrial...
Pros and cons of PreTAVR PCI, ACTIVATION trial attempts at clearing the confusion dr. Abhimanyu Uppal4 Oct 2021 3:30 AM GMTThe prevalence of coronary artery disease (CAD) among TAVR recipients is quite high, reaching up to 80%. Percutaneous coronary intervention (PCI) in...
DOACs safer than warfarin analogues for TAVR patients, JACC study. dr. Abhimanyu Uppal16 Aug 2021 4:00 AM GMTThe choice of optimal drug for anticoagulation after transcatheter aortic valve replacement (TAVR) remains debated. Recommendations on antithrombotic...
